NCOA/SCOS 2022 Joint Conference - February 11, 2022
Claiming Credit
Thank you for participating in this program. Once logged in, please click on "Register" or "Take Course" button above or on the right-hand side and your enrollment will be recorded. You will be prompted to complete the evaluation and claim your credit on the following page.
Oncology health care providers must constantly adjust to changes in cancer care related to the rapid pace of research and evolving rules and regulations affecting practice and payment. These changes can influence clinical guidelines and best practices in cancer care. They may lead to changes in how providers run their practices and patients navigate treatment options. The COVID-19 pandemic has increased demands on providers to keep up while continuing to provide their patients the care they need.
Target Audience
Pharmacists, Physician Assistants, Nurses, Nurse Practitioners
Learning Objectives
At the end of this educational activity, participants should be able to:
- Summarize new research and standards of care for various types of cancer.
- Use new knowledge of state and federal legislation to support cost-effective decision-making without compromising the quality of patient care and to support patients in navigating financial impact of cancer care.
- Explain changes in ABIM requirements for the maintenance of certification.
- Describe the impact of the COVID-19 pandemic on patients.
- Examine how the COVID-19 pandemic has affected their ability to achieve work-life balance.
Saturday January 29, 2022
7:40 AM Virtual Registration Open
7:50 AM Welcome and Introductions
Benjamin M. Parsons, DO
President, Wisconsin Association of Hematology and Oncology
Session I Moderator: Sailaja Kamaraju, MD, MS
Medical College of Wisconsin
8:00 AM Localized Therapy: Updates from a Surgery Perspective
Meeghan A Lautner, MD, FACS
University of Wisconsin School of Medicine and Public Health
8:30 AM Localized Therapy: Recent Advances in Radiotherapy for Breast Cancer
Adam Currey, MD
Medical College of Wisconsin
9:00 AM Break
9:10 AM Advances in HER2 Positive Breast Cancer
William Gradishar, MD Robert H. Lurie Comprehensive Cancer Center of Northwestern University Northwestern University Feinberg School of Medicine
9:40 AM Break
9:50 AM Updates in Triple Negative Breast Cancer
Lubna Chaudhary, MD, MS
Medical College of Wisconsin
10:20 AM Break
Session II Moderator: Kari B. Wisinski, MD
University of Wisconsin Carbone Cancer Center
10:30 AM Updates in Hormone Receptor Positive Breast Cancer
Ruth O’ Regan, MD
University of Rochester
11:00 AM Break
11:10 AM Precision Medicine and Genomic Update
Mark E. Burkard, MD, PhD
University of Wisconsin Carbone Cancer Center
11:40 AM Break
11:50 AM CNS Metastasis in Breast Cancer and Treatment Updates
Sailaja Kamaraju, MD, MS Medical College of Wisconsin
12:20 PM Wrap-Up and Acknowledgements
Physicians: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Boston University School of Medicine and the North Carolina Oncology Association and the South Carolina Oncology Society.
Boston University School of Medicine designates this live activity for a maximum of 3.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses: Boston University School of Medicine Continuing Nursing Education is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
This educational activity has been provided by Boston University School of Medicine Continuing Nursing Education and jointly provided by the North Carolina Oncology Association and the South Carolina Oncology Society.
Contact Hours: 3.25
Available Credit
- 3.75 AMA PRA Category 1 Credit™
Boston University Chobanian & Avedisian School of Medicine designates this Enduring activity for a maximum of 3.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 3.25 ANCC
- 2.00 ANCC Pharmacology
- 3.75 Participation